Keywords
intracochlear schwannoma - sensorineural hearing loss - acoustic neuroma - temporal
bone tumor - transotic approach - magnetic resonance imaging
Introduction
Schwannomas of the eighth cranial nerve are benign tumors that usually occur in the
internal auditory canal (IAC) or the cerebellopontine angle cistern. Rarely, these
tumors may originate from the neural elements within the vestibule, cochlea, or semicircular
canals and are called intralabyrinthine schwannomas (ILSs).[1]
[2] Intracochlear schwannomas (ICSs) represent a small percentage of these tumors, and
their diagnosis is based on high-resolution magnetic resonance imaging (MRI).
The aim of this article is to report the clinical and radiologic features of an ICS
in a 48-year-old man after a 22-month follow-up period.
Case Report
A 48-year-old man presented to our clinic with an 8-year history of persistent tinnitus
in his right ear, combined with ipsilateral progressive hearing loss and aural fullness.
He did not report vertigo, ototoxic exposure, a history of otitis media or trauma,
or a similar familial history.
Upon physical examination, there were no otologic findings, facial palsy, or any other
affected cranial nerves. Audiological examination revealed normal hearing in the left
ear and moderate to severe sensorineural hearing loss in the right ear, with a speech
reception threshold (SRT) of 80 dB and a word recognition score (WRS) of 58%. An audiogram
obtained 7 years previously showed mild to moderate hearing loss in the right ear,
and the patient had an SRT of 55 dB and a normal WRS of 92%.
MRI demonstrated a small intracochlear nodular lesion (diameter, 3.0 mm) in the modiolus,
with a diffuse contrast in the apical turn, isointense on T1 ([Fig. 1]) with a high contrast enhancement on T1 postgadolinium images ([Fig. 2]). The lesion showed sharply delineated edges on enhanced T1-weighted images and
sharply delineated signal intensity loss in the high-intensity intralabyrinthine fluid
on heavily T2-weighted images ([Fig. 3]). After 22 months, there were no symptomatic or audiologic changes and MRI presented
the same images.
Fig. 1 Axial T1-weighted magnetic resonance image evidencing an isointense mass on T1 limited
to the right cochlea.
Fig. 2 Axial postcontrast T1-weighted image showing enhancement in the modiolus (arrow)
of the right cochlea.
Fig. 3 Axial T2-weighed magnetic resonance image of the inner ear showing an intracochlear
schwannoma as a hypointense mass that has replaced the normal fluid of the right cochlea
(arrow).
Discussion
ILSs can be subclassified into seven groups according to the inner ear structures
that are affected: intravestibular, intracochlear, intravestibulocochlear, transmodiolar,
transmacular, transotic, and tympanolabyrinthine.[2] Approximately 100 cases of ILSs have been reported.[3] The most common type of ILS is the intravestibular, and the least common types are
the intravestibulocochlear and the transotic.[2] Schwannomas that are confined exclusively to the cochlea are extremely rare.
Schwann cells of the cochlear axons in the cochlear nerve are present in the modiolus,
proximal to the spiral ganglion.[1]
[3] Therefore, an ICS could arise in the modiolus and could then grow from the modiolus,
occupy the cochlear basal turn, erode the cribriform area of the IAC, and spread into
the vestibule.
In previous reports on patients with ICS, the most prevalent presenting symptoms were
unilateral hearing loss, varying from 93 to 100%, followed by tinnitus (50%), vertigo
(30 to 51%), imbalance, and aural fullness. The hearing loss is usually sensorineural
and progressive, typically along with poor speech recognition ability, although ∼15
to 32% of patients can present with sudden hearing loss.[1]
[2]
[4]
[5]
[6]
[7] Occasionally, a mixed-type hearing loss can occur, presumably due to increased intracochlear
impedance.[2] These tumors may cause secondary endolymphatic hydrops, resulting in disequilibrium
and vertigo.[4]
[5]
[6]
[7]
Before the MRI era, these rare tumors were sporadically identified during surgical
procedures of the inner ear or during postmortem autopsies.[3]
[4]
[5]
[6]
[7] In 1917, Nager first reported an ICS through the autopsy findings of a deaf and
mentally disabled patient.[8] Recent advances in MRI technology have enabled the detection of small ICS lesions
(<2 mm) and the determination of their precise localization.[2]
[3]
[4]
[7] Typically, an ICS is enhanced on T1-weighted images with gadolinium with sharply
delineated edges and shows a delineated signal loss in the high-intensity intralabyrinthine
fluid on T2-weighted images.[9] High-resolution fast spin-echo T2-weighted images and traditional T1-weighted images
with gadolinium are both equally sensitive in detecting schwannomas.[1]
[4]
[5]
[7]
The most important differential diagnosis is labyrinthitis. The MRI findings of ICS
may mimic those of infectious or inflammatory processes. However, acute infectious
or inflammatory processes are usually normal on T2-weighted images, and an ICS may
present as a filling defect. Labyrinthitis demonstrates an enhancement, which is often
pronounced and less sharp and most commonly affects the complete cochlea or the vestibular
system. However, this enhancement becomes weaker and may disappear on follow-up.[9]
[10]
In rare cases of focal enhancement, labyrinthitis can be distinguished by performing
a high-resolution thin-section T2-weighted study.[5]
[7] In acute labyrinthitis, no soft tissue mass or filling defect is seen in the labyrinth.
Chronic labyrinthitis shows T2 signal intensity loss within labyrinth and often demonstrates
T1 postcontrast enhancement during its fibrous stage and no enhancement at ossific
stage.[5]
[7] Labyrinthitis may enhance on T1 postcontrast during its fibro-osseous phase and
show T2 signal intensity loss within the inner ear, despite the intensity loss is
usually unsharp. It could be diagnosed by obtaining a full medical history and performing
temporal bone computed tomography (CT), although the CT can be normal in the early
stages.[5]
[7]
Hemorrhage has a variable signal on T2-weighted images but appears as a high signal
intensity lesion on T1-weighted images without contrast enhancement.[5]
[7] Lipoma, although rare, could also present as hyperintense lesion on T1-weighted
images and hypointensity on fat-suppression sequences. Therefore, T1-weighted postcontrast
enhanced images are essential to confirm that a lesion is a schwannoma.[5]
[7]
Once diagnosed, not all ICS patients require surgery. The treatment of ICS depends
on the tumor's size, evidence of the tumor's growth, degree of hearing loss, intractable
vestibular symptoms, concern about the pathologic diagnosis, and the patient's other
medical conditions.[1]
[4]
[5]
[6] Preservation of hearing is not an option in the surgical removal of these tumors.
The suggested surgical access is transotic, as it allows a good exposure of the inner
ear structures and the IAC.[3]
[4]
[5]
[6] Studies have also reported successful tumor removal with a transcanal labyrinthectomy
or a translabyrinthine approach.[1]
[2]
[5]
[6]
Stereotactic radiotherapy is a treatment option for an ICS patient who has a progressively
enlarging tumor but may not be eligible for surgery.[6] The risks for radiosurgery include sensorineural sequelae, increased tumor growth,
and malignant transformation. Radiosurgery is probably not effective in treating the
vestibular symptoms. A bone-anchored hearing aid may help to overcome the head shadow
effect and improve hearing.[5]
The suggested follow-up examination is rescanning at 12 months after the initial diagnosis.
If the ICS has not grown, an MRI scan should be repeated every 2 years. Our patient's
main complaint was hearing loss, but he presented with residual hearing, without any
vestibular symptoms. Moreover, we decided to pursue a wait-and-scan policy because
in the previous 22 months, the lesion had remained stable, showing no considerable
growth.
